HIGHLIGHTS
- What: The aim of this observational registry study was therefore to describe the outcome of children and adolescents with C3G or IC-MPGN following KTx and to compare their outcome with a matched control group of children with other primary kidney diseases that are not associated with the development of recurrent disease following transplantation. The study was designed, analyzed, and reported according to the STROBE guidelines (https://w ww. strobe-statement.org). The authors report here the largest series to date of pediatric patients with C3G or IC-MPGN who had received a KTx, because their . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.